129 related articles for article (PubMed ID: 21804377)
1. Reduction of resting heart rate with antianginal drugs: review and meta-analysis.
Cucherat M; Borer JS
Am J Ther; 2012 Jul; 19(4):269-80. PubMed ID: 21804377
[TBL] [Abstract][Full Text] [Related]
2. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
3. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
[TBL] [Abstract][Full Text] [Related]
5. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
[TBL] [Abstract][Full Text] [Related]
6. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials.
Mozaffarian D; Geelen A; Brouwer IA; Geleijnse JM; Zock PL; Katan MB
Circulation; 2005 Sep; 112(13):1945-52. PubMed ID: 16172267
[TBL] [Abstract][Full Text] [Related]
7. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
Bruguera Cortada J; Varela A
Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
[TBL] [Abstract][Full Text] [Related]
8. Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
Daly CA; Clemens F; Sendon JL; Tavazzi L; Boersma E; Danchin N; Delahaye F; Gitt A; Julian D; Mulcahy D; Ruzyllo W; Thygesen K; Verheugt F; Fox KM;
Postgrad Med J; 2010 Apr; 86(1014):212-7. PubMed ID: 20354044
[TBL] [Abstract][Full Text] [Related]
9. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
[No Abstract] [Full Text] [Related]
10. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
López-Bescós L; Filipova S; Martos R
Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine: new drug. Best avoided in stable angina.
Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
[TBL] [Abstract][Full Text] [Related]
12. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
Celik O; Atasoy MM; Ertürk M; Yalçın AA; Aksu HU; Diker M; Aktürk IF; Atasoy I
Acta Radiol; 2014 Jul; 55(6):676-81. PubMed ID: 24052362
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Bowles MJ; Smith L; Glover DR
J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
[TBL] [Abstract][Full Text] [Related]
14. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
Sun Y; Yu J; Hu D;
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
16. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an ambulatory population with stable coronary artery disease and importance of heart rate: the PULSAR registry.
Seabra-Gomes R;
Rev Port Cardiol; 2010 Apr; 29(4):483-508. PubMed ID: 20734572
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
Tendera M; Borer JS; Tardif JC
Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
Köster R; Kaehler J; Meinertz T;
Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403
[TBL] [Abstract][Full Text] [Related]
20. Ivabradine: recent and potential applications in clinical practice.
Riccioni G
Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
